Topical tazarotene chemoprevention reduces basal cell carcinoma number and size and Ptch1+/- mice exposed to ultraviolet or ionizing radiation

Cancer Research

Volumn 64, Issue 13, 2004, Pages 4385-4389

  So, Po Lin ^a   Lee, Kenneth ^a   Hebert, Jennifer ^a   Walker, Patricia ^c   Lu, Ying ^a,b   Hwang, Jimmy ^b   Kopelovich, Levy ^e   Athar, Mohammed ^d   Bickers, David ^d   Aszterbaum, Michelle ^a   Epstein Jr , Ervin H ^a,b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALLERGAN INC   (United States)

^d New York Presbyterian Hospital Columbia University Medical Center   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID; TAZAROTENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG RESEARCH; DRUG SCREENING; FEMALE; GENETIC SUSCEPTIBILITY; IONIZING RADIATION; MALE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; ULTRAVIOLET RADIATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOMA, BASAL CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASMS, RADIATION-INDUCED; NICOTINIC ACIDS; PROTEINS; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 3042778719     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1927     Document Type: Article

References (39)

1. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001;1:181-93.
2. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996;10:1002-13.
3. Peck GL, DiGiovanna JJ, Sarnoff DS, et al. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 1988;19:176-85.
4. Epstein JH, Grekin DA. Inhibition of ultraviolet-induced carcinogenesis by all-trans retinoic acid. J Investig Dermatol 1981;76:178-80.
5. Forbes PD, Urbach F, Davies RE. Enhancement of experimental photocarcinogenesis by topical retinoic acid. Cancer Lett 1979;7:85-90.
6. Kligman LH, Kligman AM. Lack of enhancement of experimental photocarcinogenesis by topical retinoic acid. Arch Dermatol Res 1981;270:453-62.
7. Kligman LH, Crosby MJ. Topical tretinoin enhances corticosteroid-induced inhibition of tumorigenesis in hairless mice previously exposed to solar simulating radiation. Cancer Lett 1996;107:217-22.
8. Nagpal S, Chandraratna RA. Recent developments in receptor-selective refinoids. Curr Pharm Des 2000;6:919-31.
9. Peris K, Fargnoli MC, Chimenti S. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. N Engl J Med 1999;341:1767-8.
10. Aszterbaum M, Epstein J, Oro A, et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 1999;5:1285-91.
11. Mancuso M, Pazzaglia S, Tanori M, et al. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice. Cancer Res 2004;64: 934-41.
12. Saurat JH. Skin, sun, and vitamin A: from aging to cancer. J Dermatol 2001;28: 595-8.
13. Antille C, Tran C, Sorg O, et al. Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation. J Investig Dermatol 2003;121:1163-7.
14. Peck GL. Long-term retinoid therapy is needed for maintenance of cancer chemopreventive effect. Dermatologica 1987;175(Suppl 1):138-44.
15. Morison WL, Jerdan MS, Hoover TL, Farmer ER. UV radiation-induced tumors in haired mice: identification as squamous cell carcinomas. J Natl Cancer Inst (Bethesda) 1986;77:1155-62.
16. Portella G, Cumming SA, Liddell J, et al. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 1998;9:393-404.
17. Cui W, Fowlis DJ, Bryson S, et al. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996;86:531-42.
18. Ingham PW. The patched gene in development and cancer. Curr Opin Genet Dev 1998;8:88-94.
19. Murone M, Rosenthal A, de Sauvage FJ. Hedgehog signal transduction: from flies to vertebrates. Exp Cell Res 1999;253:25-33.
20. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85: 841-51.
21. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science (Wash DC) 1996;272:1668-71.
22. Aszterbaum M, Rothman A, Johnson RL, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Investig Dermatol 1998;110:885-8.
23. Bogovski P. Tumours of the skin. IARC Sci Publ 1994;111:1-45.
24. Chandraratna RA. Tazarotene: first of a new generation of receptor-selective retinoids. Br J Dermatol 1996;135(Suppl 49):18-25.
25. Eklund LK, Lindstrom E, Unden AB, et al. Mutation analysis of the human homologue of Drosophila patched and the xeroderma pigmentosum complementation group A genes in squamous cell carcinomas of the skin. Mol Carcinog 1998;21:87-92.
26. Xie J, Aszterbaum M, Zhang X, et al. A role of PDGFRalpha in basal cell carcinoma proliferation. Proc Natl Acad Sci USA 2001;98:9255-9.
27. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J Dermatol Sci 1998;17:1-7.
28. Goyette P, Allan D, Peschard P, et al. Regulation of gli activity by all-trans retinoic acid in mouse keratinocytes. Cancer Res 2000;60:5386-9.
29. Li M, Indra AK, Warot X, et al. Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature (Lond) 2000;407:633-6.
30. Xu XC, Wong WY, Goldberg L, et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 2001;61:4306-10.
31. Kamradt J, Reichrath J. Expression of retinoic acid receptor proteins in basal cell carcinomas: an immunohistochemical analysis. J Histochem Cytochem 1996;44: 1415-20.
32. DiSepio D, Ghosn C, Eckert RL, et al. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci USA 1998;95:14811-5.
33. Duvic M, Helekar B, Schulz C, et al. Expression of a retinoid-inducible tumor suppressor, tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res 2000;6:3249-59.
34. Duvic M, Ni X, Talpur R, et al. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Investig Dermatol 2003;121:902-9.
35. Jing C, El-Ghany MA, Beesley C, et al. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst (Bethesda) 2002;94:482-90.
36. Lotan R. Is TIG1 a new tumor suppressor in prostate cancer? J Natl Cancer Inst (Bethesda) 2002;94:469-70.
37. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature (Lond) 2003;425:851-6.
38. Watkins DN, Berman DM, Burkholder SG, et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature (Lond) 2003;422:313-7.
39. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature (Lond) 2003;425: 846-51.